Get started
Author

Lars-Olof Larsson

Observed names: Lars-Olof. Larsson, Lars‐Olof Larsson
OpenAlex ID: A5113544285
Pulmonary disease by non-tuberculous mycobacteria – clinical management, unmet needs and future perspectives
2017 · Lars-Olof Larsson, Eva Polverino, et al. · Expert Review of Respiratory Medicine · 74
PDF
Discovery of AZD2716: A Novel Secreted Phospholipase A2 (sPLA2) Inhibitor for the Treatment of Coronary Artery Disease
2016 · Fabrizio Giordanetto, Daniel Pettersen, et al. · ACS Medicinal Chemistry Letters · 41
PDF
Food incentives improve adherence to tuberculosis drug treatment among homeless patients in Russia
2012 · Bodil Gärden, Arina Samarina, et al. · Scandinavian Journal of Caring Sciences · 35
Discovery of cyclopentane- and cyclohexane-trans-1,3-diamines as potent melanin-concentrating hormone receptor 1 antagonists
2007 · Fabrizio Giordanetto, Olle Karlsson, et al. · Bioorganic & Medicinal Chemistry Letters · 26
Interpersonal behaviors and socioemotional interaction of medical students in a virtual clinical encounter
2014 · Olivier Courteille, Anna Josephson, et al. · BMC Medical Education · 25
PDF
Experience of Guilt and Strategies for Coping with Guilt in Patients with Severe Copd: A Qualitative Interview Study
2014 · Susann Strang, Mary Farrell, et al. · Journal of Palliative Care · 24
Palliative care in COPD—web survey in Sweden highlights the current situation for a vulnerable group of patients
2013 · Susann Strang, Ann Ekberg-Jansson, et al. · Upsala Journal of Medical Sciences · 20
PDF
Impact of Input Parameters on the Prediction of Hepatic Plasma Clearance Using the Well-Stirred Model
2010 · Hong Wan, Peter Bold, et al. · Current Drug Metabolism · 20
Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays
2017 · Giovanni Ferrara, Davide Valentini, et al. · International Journal of Infectious Diseases · 11
PDF
Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting
2013 · Platon I. Eliseev, Andrey O. Maryandyshev, et al. · International Journal of Mycobacteriology · 8
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
2023 · Ali Vaeli Zadeh, Roshan Dinparastisaleh, et al. · Annals of the American Thoracic Society · 7
Nontuberculous Mycobacterial Diseases in Humans
2019 · Lars-Olof. Larsson, Rutger Bennet, et al. · Elsevier eBooks · 5
New approaches in drug treatment for tuberculosis
2016 · Lars-Olof Larsson · International Journal of Mycobacteriology · 4
PDF
List of Contributors
2019 · Imran Ahmed, Rutger Bennet, et al. · Elsevier eBooks
Implementation of a new model for TB-care in a low endemic setting
2015 · Viktor Storberg, Mary Farrell, et al. · International Journal of Mycobacteriology
Implementing joint tuberculosis projects in Somaliland and Sweden for mutual strengthening of programs and research
2014 · Abdi Yassin, Adam M. Saeed, et al. · International Journal of Mycobacteriology
PDF
Implementation of a new model for TB-care in a low endemic setting: A challenge in vain?
2014 · Viktor Storberg, Mary Farrell, et al. · International Journal of Mycobacteriology
Epidemiological analyses of tuberculosis in Archangelsk, Russia and implementation of a rapid assay for detection of resistance in this high burden setting
2013 · Platon Eliseev, Andrey Maryandyshev, et al. · F1000Research
BCG vaccination of young adults at risk of tuberculosis: a meaningful precaution in low-prevalence settings? [Correspondence]
2011 · Lars-Olof Larsson, Harald Fjällbrant, et al. · The International Journal of Tuberculosis and Lung Disease
[Tuberculosis--still increasing threat. Time for mobilization over the national borders].
2009 · Lars-Olof Larsson · PubMed
Works count: 20
Citation count: 300
H-index: 9
I10-index: 9
Year
Topic
Type